Stay updated on Nivolumab Post-chemoradiotherapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Post-chemoradiotherapy Clinical Trial page.

Latest updates to the Nivolumab Post-chemoradiotherapy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedDifference0.1%

- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page has been updated to a newer ClinicalTrials.gov revision version (v3.5.3 instead of v3.5.2), reflecting a site update rather than any change to the underlying study information.SummaryDifference0.1%

- Check40 days agoChange DetectedOno Pharmaceutical Co., Ltd. is added as a collaborator with the standardized company name. The page revision is updated to v3.5.2, replacing the previous Ono Pharmaceutical Co. Ltd and revision v3.5.0.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check104 days agoChange DetectedThe site revision label in the footer was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Post-chemoradiotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Post-chemoradiotherapy Clinical Trial page.